Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
RAGE receptor binding (GO:0050786),3/9,3.857340151791266e-6,6.056024038312288e-4,0,0,142.29285714285714,1773.7562625323076,S100A12;S100A9;S100A8
MHC class II protein complex binding (GO:0023026),3/17,3.0577748716090986e-5,0.0024003532742131422,0,0,60.95816326530612,633.674613945843,CD74;PKM;HLA-DRA
protein homodimerization activity (GO:0042803),10/636,1.0068012980613892e-4,0.005268926793187937,0,0,4.894010852477306,45.04233279103702,SFPQ;PLEK;PSAP;MYH9;FLNA;DEFA3;TKT;B2M;SYNE1;MCL1
icosatetraenoic acid binding (GO:0050543),2/6,1.952441783803584e-4,0.006130667201143253,0,0,140.30281690140845,1198.3627797911195,S100A9;S100A8
arachidonic acid binding (GO:0050544),2/6,1.952441783803584e-4,0.006130667201143253,0,0,140.30281690140845,1198.3627797911195,S100A9;S100A8
icosanoid binding (GO:0050542),2/7,2.726962614621149e-4,0.00713555217492534,0,0,112.23661971830985,921.142995474641,S100A9;S100A8
L-glutamine transmembrane transporter activity (GO:0015186),2/8,3.6273631743584525e-4,0.008135657405346814,0,0,93.52582159624413,740.8960694909396,SLC38A1;SLC38A2
amino acid:sodium symporter activity (GO:0005283),2/11,7.074828428562862e-4,0.012341645147604103,0,0,62.341158059467915,452.21011647488814,SLC38A1;SLC38A2
Toll-like receptor binding (GO:0035325),2/11,7.074828428562862e-4,0.012341645147604103,0,0,62.341158059467915,452.21011647488814,S100A9;S100A8
cadherin binding (GO:0045296),6/322,0.0011442283754702289,0.016911674392874446,0,0,5.557623276024938,37.641920149972165,DDX3X;PKM;MYH9;FLNA;OLFM4;TLN1
transition metal ion binding (GO:0046914),7/445,0.001184894384214133,0.016911674392874446,0,0,4.719212674692127,31.79853464214659,LCN2;S100A12;MMP8;MMP9;S100A9;S100A8;LTF
hexose transmembrane transporter activity (GO:0015149),2/15,0.0013379471101985043,0.017504808025097098,0,0,43.15059588299025,285.51104598113415,SLC2A3;PPBP
glucose transmembrane transporter activity (GO:0005355),2/21,0.002638278864357178,0.03186229090031361,0,0,29.515196441808747,175.25027215896412,SLC2A3;PPBP
poly(A) binding (GO:0008143),2/22,0.0028952732366765354,0.03246842129701543,0,0,28.038028169014083,163.87318444267802,DDX3X;HNRNPDL
amyloid-beta binding (GO:0001540),3/80,0.003133977417490171,0.03280229696973046,0,0,11.048237476808906,63.69808662155511,CD74;ITGB2;ITM2B
actin binding (GO:0003779),4/177,0.0040141458450732685,0.039388806104781446,0,0,6.619418614392226,36.52549315652849,CAP1;MYH9;LCP1;SYNE1
poly-purine tract binding (GO:0070717),2/28,0.004671236517216912,0.04074356295572529,0,0,21.56121343445287,115.70461804458127,DDX3X;HNRNPDL
MHC protein binding (GO:0042287),2/28,0.004671236517216912,0.04074356295572529,0,0,21.56121343445287,115.70461804458127,CD74;HLA-E
protein heterodimerization activity (GO:0046982),4/188,0.00496811036896797,0.04105228041726165,0,0,6.220226843100189,32.99653510798739,CYBB;CEACAM8;HIF1A;MCL1
monocarboxylic acid binding (GO:0033293),2/31,0.005705947915146924,0.04479169113390335,0,0,19.327829043224867,99.85232246586659,PSAP;PYGL
neutral amino acid transmembrane transporter activity (GO:0015175),2/32,0.006072049769721403,0.04539580065934573,0,0,18.68262910798122,95.35724203305122,SLC38A1;SLC38A2
zinc ion binding (GO:0008270),5/336,0.00768313620554293,0.05482965383046546,0,0,4.353118891060956,21.194149460145077,S100A12;MMP8;MMP9;S100A9;S100A8
protein serine/threonine kinase activator activity (GO:0043539),2/37,0.008057974182139549,0.055004432460691706,0,0,16.009657947686115,77.18405140445952,DDX3X;LTF
calcium ion binding (GO:0005509),5/348,0.008864284723489161,0.0579871958994916,0,0,4.198250728862973,19.839778543882186,S100A12;LCP1;TKT;S100A9;S100A8
ATP hydrolysis activity (GO:0140603),2/45,0.011755406983254994,0.07382395585484136,0,0,13.025876187356697,57.87972501790881,DDX3X;RNF213
RNA binding (GO:0003723),11/1406,0.012641487245803456,0.07417873350794693,0,0,2.356942999190658,10.301658664183194,SFPQ;GRN;DDX3X;PKM;HNRNPDL;MYH9;FLNA;YBX1;HLA-A;RBMX;SYNE1
cation transmembrane transporter activity (GO:0008324),2/48,0.01330025983053789,0.07417873350794693,0,0,12.174525413349663,52.59360534174025,SLC38A1;SLC38A2
amino acid transmembrane transporter activity (GO:0015171),2/49,0.013833808022784779,0.07417873350794693,0,0,11.914893617021276,51.00336814079256,SLC38A1;SLC38A2
L-amino acid transmembrane transporter activity (GO:0015179),2/53,0.01605905442556056,0.07417873350794693,0,0,10.978182822424744,45.35616966163476,SLC38A1;SLC38A2
iron ion binding (GO:0005506),2/54,0.016637771492323223,0.07417873350794693,0,0,10.766522210184181,44.100533896965025,LCN2;LTF
"1,4-alpha-oligoglucan phosphorylase activity (GO:0004645)",1/5,0.018118915662048707,0.07417873350794693,0,0,69.17708333333333,277.45536435713205,PYGL
RNA strand annealing activity (GO:0033592),1/5,0.018118915662048707,0.07417873350794693,0,0,69.17708333333333,277.45536435713205,DDX3X
complement component C3b binding (GO:0001851),1/5,0.018118915662048707,0.07417873350794693,0,0,69.17708333333333,277.45536435713205,ITGB2
cytoskeleton-nuclear membrane anchor activity (GO:0140444),1/5,0.018118915662048707,0.07417873350794693,0,0,69.17708333333333,277.45536435713205,SYNE1
"alpha-1,4-glucosidase activity (GO:0004558)",1/5,0.018118915662048707,0.07417873350794693,0,0,69.17708333333333,277.45536435713205,MGAM
LIM domain binding (GO:0030274),1/5,0.018118915662048707,0.07417873350794693,0,0,69.17708333333333,277.45536435713205,TLN1
annealing activity (GO:0097617),1/5,0.018118915662048707,0.07417873350794693,0,0,69.17708333333333,277.45536435713205,DDX3X
ganglioside binding (GO:0035594),1/5,0.018118915662048707,0.07417873350794693,0,0,69.17708333333333,277.45536435713205,PSAP
carboxylic acid transmembrane transporter activity (GO:0046943),2/57,0.018426564374585543,0.07417873350794693,0,0,10.177720870678618,40.649429788478564,SLC38A1;SLC38A2
alpha-glucosidase activity (GO:0090599),1/6,0.02170366274746418,0.07744261480345173,0,0,55.33888888888889,211.9631207182121,MGAM
L-serine transmembrane transporter activity (GO:0015194),1/6,0.02170366274746418,0.07744261480345173,0,0,55.33888888888889,211.9631207182121,SLC38A2
BH domain binding (GO:0051400),1/6,0.02170366274746418,0.07744261480345173,0,0,55.33888888888889,211.9631207182121,MCL1
BH3 domain binding (GO:0051434),1/6,0.02170366274746418,0.07744261480345173,0,0,55.33888888888889,211.9631207182121,MCL1
MHC class II protein binding (GO:0042289),1/6,0.02170366274746418,0.07744261480345173,0,0,55.33888888888889,211.9631207182121,CD74
protein kinase activator activity (GO:0030295),2/63,0.022234793704465437,0.07757472470224608,0,0,9.173862849226506,34.91661125444899,DDX3X;LTF
organic acid:sodium symporter activity (GO:0005343),1/7,0.025275502302547336,0.08626638829347678,0,0,46.113425925925924,169.6014749165987,SLC38A1
purine ribonucleoside triphosphate binding (GO:0035639),5/460,0.02638770504498257,0.08814616366089922,0,0,3.1467356173238525,11.437934285673082,TUBA1A;STK17B;TUBB1;MYH9;PYGL
serine transmembrane transporter activity (GO:0022889),1/8,0.028834479875414456,0.0905402668088014,0,0,39.523809523809526,140.15867684434946,SLC38A2
poly(G) binding (GO:0034046),1/8,0.028834479875414456,0.0905402668088014,0,0,39.523809523809526,140.15867684434946,HNRNPDL
CD4 receptor binding (GO:0042609),1/8,0.028834479875414456,0.0905402668088014,0,0,39.523809523809526,140.15867684434946,CD74
bile acid binding (GO:0032052),1/9,0.03238064093072697,0.09240667294002278,0,0,34.58159722222222,118.62160586885466,PYGL
protein-glutamine gamma-glutamyltransferase activity (GO:0003810),1/9,0.03238064093072697,0.09240667294002278,0,0,34.58159722222222,118.62160586885466,F13A1
natural killer cell lectin-like receptor binding (GO:0046703),1/9,0.03238064093072697,0.09240667294002278,0,0,34.58159722222222,118.62160586885466,HLA-E
adenylate cyclase binding (GO:0008179),1/10,0.03591403083014349,0.09240667294002278,0,0,30.737654320987655,102.25271781730339,CAP1
endopeptidase activator activity (GO:0061133),1/10,0.03591403083014349,0.09240667294002278,0,0,30.737654320987655,102.25271781730339,VSIR
Lys63-specific deubiquitinase activity (GO:0061578),1/10,0.03591403083014349,0.09240667294002278,0,0,30.737654320987655,102.25271781730339,TNFAIP3
eukaryotic initiation factor 4E binding (GO:0008190),1/10,0.03591403083014349,0.09240667294002278,0,0,30.737654320987655,102.25271781730339,DDX3X
MHC class II receptor activity (GO:0032395),1/10,0.03591403083014349,0.09240667294002278,0,0,30.737654320987655,102.25271781730339,HLA-DRA
ubiquitination-like modification-dependent protein binding (GO:0140035),1/10,0.03591403083014349,0.09240667294002278,0,0,30.737654320987655,102.25271781730339,LAPTM5
metalloendopeptidase activity (GO:0004222),2/82,0.0361751688261929,0.09240667294002278,0,0,6.988380281690141,23.197106089070086,MMP8;MMP9
GTPase binding (GO:0051020),3/201,0.03723729038224064,0.09240667294002278,0,0,4.27034632034632,14.051337947935814,FLNA;YBX1;LCP1
death domain binding (GO:0070513),1/11,0.039434694821538385,0.09240667294002278,0,0,27.6625,89.43588520720674,MCL1
AMP binding (GO:0016208),1/11,0.039434694821538385,0.09240667294002278,0,0,27.6625,89.43588520720674,PYGL
superoxide-generating NAD(P)H oxidase activity (GO:0016175),1/11,0.039434694821538385,0.09240667294002278,0,0,27.6625,89.43588520720674,CYBB
filamin binding (GO:0031005),1/11,0.039434694821538385,0.09240667294002278,0,0,27.6625,89.43588520720674,RFLNB
ubiquitin-dependent protein binding (GO:0140036),1/11,0.039434694821538385,0.09240667294002278,0,0,27.6625,89.43588520720674,LAPTM5
vinculin binding (GO:0017166),1/11,0.039434694821538385,0.09240667294002278,0,0,27.6625,89.43588520720674,TLN1
metal ion binding (GO:0046872),5/517,0.040524452165121023,0.09356380867535294,0,0,2.788229549632353,8.938644948571877,S100A12;LCP1;TKT;S100A9;S100A8
cytokine receptor activity (GO:0004896),2/88,0.04112206669644483,0.09356760103393968,0,0,6.498853586636096,20.739209147060983,CD74;CSF3R
RNA stem-loop binding (GO:0035613),1/12,0.042942678013426154,0.09631429211582723,0,0,25.146464646464647,79.15828251915687,DDX3X
"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",1/15,0.05339099174661933,0.11806177048196105,0,0,19.754960317460316,57.88427080418689,CYBB
serine-type endopeptidase activity (GO:0004252),2/105,0.056395112230582814,0.1229726752805764,0,0,5.4215780117598795,15.589057876591914,MMP8;MMP9
ribosomal small subunit binding (GO:0043024),1/17,0.06029395078422422,0.12621533697497603,0,0,17.283854166666668,48.54211057952261,DDX3X
CXCR chemokine receptor binding (GO:0045236),1/17,0.06029395078422422,0.12621533697497603,0,0,17.283854166666668,48.54211057952261,PPBP
MHC class I protein binding (GO:0042288),1/17,0.06029395078422422,0.12621533697497603,0,0,17.283854166666668,48.54211057952261,HLA-E
protease binding (GO:0002020),2/118,0.06919918988758013,0.14158961184227414,0,0,4.810830500242837,12.848603124765257,PSAP;TNFAIP3
mRNA binding (GO:0003729),3/263,0.07152552776148045,0.14158961184227414,0,0,3.2418131868131868,8.550933435269775,DDX3X;PKM;RBMX
metallopeptidase activity (GO:0008237),2/121,0.07227864004603228,0.14158961184227414,0,0,4.688838915848029,12.318642456532933,MMP8;MMP9
ubiquitin protein ligase binding (GO:0031625),3/265,0.07280765262527335,0.14158961184227414,0,0,3.2167393675027265,8.427645516228054,NFKBIA;LAPTM5;HIF1A
N-acetyltransferase activity (GO:0008080),1/21,0.07395126223609223,0.14158961184227414,0,0,13.824305555555556,36.00331664229168,SAT1
pyridoxal phosphate binding (GO:0030170),1/21,0.07395126223609223,0.14158961184227414,0,0,13.824305555555556,36.00331664229168,PYGL
histone acetyltransferase binding (GO:0035035),1/21,0.07395126223609223,0.14158961184227414,0,0,13.824305555555556,36.00331664229168,HIF1A
serine-type peptidase activity (GO:0008236),2/125,0.07645268170890704,0.14284208433380924,0,0,4.5354402839803045,11.660994632947268,MMP8;MMP9
peptidase activator activity (GO:0016504),1/22,0.07733488642276296,0.14284208433380924,0,0,13.165343915343914,33.69814742858341,VSIR
K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),1/22,0.07733488642276296,0.14284208433380924,0,0,13.165343915343914,33.69814742858341,TNFAIP3
gamma-tubulin binding (GO:0043015),1/23,0.08070631631088798,0.14512513274899017,0,0,12.566287878787879,31.62857298179009,DDX3X
nucleoside-triphosphatase activity (GO:0017111),3/278,0.08139093190661578,0.14512513274899017,0,0,3.062649350649351,7.682629599638841,DDX3X;RNF213;MYH9
ATP binding (GO:0005524),3/278,0.08139093190661578,0.14512513274899017,0,0,3.062649350649351,7.682629599638841,STK17B;MYH9;PYGL
nuclear localization sequence binding (GO:0008139),1/24,0.08406559523720614,0.14512513274899017,0,0,12.019323671497585,29.76174313200534,NFKBIA
cell adhesion mediator activity (GO:0098631),1/24,0.08406559523720614,0.14512513274899017,0,0,12.019323671497585,29.76174313200534,EMB
ubiquitin-like protein ligase binding (GO:0044389),3/282,0.0841171151602427,0.14512513274899017,0,0,3.018125960061444,7.471507303066445,NFKBIA;LAPTM5;HIF1A
mRNA 5'-UTR binding (GO:0048027),1/25,0.08741276636564344,0.14756778838070989,0,0,11.517939814814815,28.070531668147478,DDX3X
NF-kappaB binding (GO:0051059),1/25,0.08741276636564344,0.14756778838070989,0,0,11.517939814814815,28.070531668147478,NFKBIA
"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",1/26,0.09074787272717313,0.15156825551240619,0,0,11.056666666666667,26.53235403248719,PLEK
ADP binding (GO:0043531),1/27,0.09407095720227293,0.15546463453428264,0,0,10.630876068376068,25.12826467235412,MYH9
G protein-coupled receptor binding (GO:0001664),2/143,0.0961219327305885,0.15719941081981662,0,0,3.9528518629507543,9.258123611223978,FCN1;FLNA
organic anion transmembrane transporter activity (GO:0008514),2/144,0.0972539017980782,0.1574109544566833,0,0,3.9248165046617736,9.146510817614471,SLC38A1;SLC38A2
adenyl ribonucleotide binding (GO:0032559),3/306,0.10127544327011753,0.16178783146584183,0,0,2.775671852899576,6.356042377150414,STK17B;MYH9;PYGL
tubulin binding (GO:0015631),3/307,0.10201907844024422,0.16178783146584183,0,0,2.7664003759398494,6.314572882384383,DDX3X;S100A9;S100A8
miRNA binding (GO:0035198),1/30,0.10396850581271733,0.1632305541259662,0,0,9.529693486590038,21.572055090315498,YBX1
acetyltransferase activity (GO:0016407),1/32,0.11050754144475816,0.17177904957254486,0,0,8.913978494623656,19.634566488548145,SAT1
Hsp90 protein binding (GO:0051879),1/35,0.12022794098244914,0.18505673268867173,0,0,8.126225490196079,17.21431840365986,HIF1A
"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",1/37,0.12664992444548392,0.193048913960592,0,0,7.673996913580247,15.85699852450674,MGAM
N-acyltransferase activity (GO:0016410),1/39,0.1330256677214299,0.20081759454100476,0,0,7.269371345029239,14.663871680193896,SAT1
cysteine-type endopeptidase inhibitor activity (GO:0004869),1/40,0.13619630195383398,0.20172471138445222,0,0,7.082621082621083,14.12032444596875,LTF
regulatory RNA binding (GO:0061980),1/40,0.13619630195383398,0.20172471138445222,0,0,7.082621082621083,14.12032444596875,YBX1
carboxylic acid binding (GO:0031406),1/41,0.1393554990817365,0.2044748911760059,0,0,6.905208333333333,13.60828094132521,PSAP
signal sequence binding (GO:0005048),1/42,0.14250329979273732,0.2052570464904565,0,0,6.736449864498645,13.125232380756088,NFKBIA
cell-cell adhesion mediator activity (GO:0098632),1/42,0.14250329979273732,0.2052570464904565,0,0,6.736449864498645,13.125232380756088,EMB
GTP binding (GO:0005525),2/189,0.1515661358846441,0.20975923690220066,0,0,2.973563304963471,5.610320635932044,TUBA1A;TUBB1
copper ion binding (GO:0005507),1/45,0.15187872804092215,0.20975923690220066,0,0,6.276199494949495,11.828583218714314,S100A12
single-stranded RNA binding (GO:0003727),1/45,0.15187872804092215,0.20975923690220066,0,0,6.276199494949495,11.828583218714314,DDX3X
protein kinase C binding (GO:0005080),1/45,0.15187872804092215,0.20975923690220066,0,0,6.276199494949495,11.828583218714314,PLEK
RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),2/190,0.15283471200748458,0.20975923690220066,0,0,2.957596643691939,5.555544375172335,NFKBIA;HIF1A
chemokine activity (GO:0008009),1/46,0.15498134701054317,0.20975923690220066,0,0,6.13641975308642,11.44105094540804,PPBP
endopeptidase regulator activity (GO:0061135),1/46,0.15498134701054317,0.20975923690220066,0,0,6.13641975308642,11.44105094540804,VSIR
lipase activity (GO:0016298),1/49,0.16422219226923945,0.22036653150658625,0,0,5.752025462962963,10.391234958525118,PLBD1
chemokine receptor binding (GO:0042379),1/50,0.1672802691231711,0.22069749791880555,0,0,5.634353741496598,10.074701240888364,PPBP
potassium channel regulator activity (GO:0015459),1/50,0.1672802691231711,0.22069749791880555,0,0,5.634353741496598,10.074701240888364,FLNA
polyubiquitin modification-dependent protein binding (GO:0031593),1/51,0.17032730933834414,0.22284489638433358,0,0,5.521388888888889,9.773042438478246,TNFAIP3
DNA binding (GO:0003677),5/811,0.17412816956376567,0.22593489769843975,0,0,1.7443621369143192,3.049081597716518,SFPQ;DDX3X;APLP2;YBX1;HIF1A
pyrophosphatase activity (GO:0016462),1/54,0.1794026022045267,0.23087056185336632,0,0,5.2080712788259955,8.948106135360762,DDX3X
flavin adenine dinucleotide binding (GO:0050660),1/55,0.18240588726064513,0.2327804643013835,0,0,5.111368312757202,8.697100140634774,CYBB
guanyl ribonucleotide binding (GO:0032561),2/214,0.1838520864545959,0.2327804643013835,0,0,2.6195854371512093,4.436592039790376,TUBA1A;TUBB1
microtubule binding (GO:0008017),2/232,0.20767870461453625,0.2608444529958575,0,0,2.412369871402327,3.791673906162222,S100A9;S100A8
motor activity (GO:0003774),1/66,0.21473490008633264,0.2675665024885256,0,0,4.244017094017094,6.528788087046047,MYH9
double-stranded RNA binding (GO:0003725),1/73,0.23464797994946024,0.2867686452426923,0,0,3.830054012345679,5.552309978509986,DDX3X
phospholipase activity (GO:0004620),1/73,0.23464797994946024,0.2867686452426923,0,0,3.830054012345679,5.552309978509986,PLBD1
kinase binding (GO:0019900),3/461,0.2370439090562791,0.2867686452426923,0,0,1.8218028696194635,2.6225032388426275,ITGB2;FLNA;HIF1A
ubiquitin binding (GO:0043130),1/74,0.23745174446847134,0.2867686452426923,0,0,3.7773972602739727,5.431107245351442,TNFAIP3
"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",1/75,0.2402453780074235,0.2879276667722557,0,0,3.7261636636636637,5.313861393498236,PKM
growth factor activity (GO:0008083),1/87,0.2729917741243003,0.32469476164784206,0,0,3.204295865633075,4.1601809509671455,GRN
protein kinase binding (GO:0019901),3/506,0.281330909527575,0.33209738944232536,0,0,1.6549843794376597,2.0988903941246644,ITGB2;PLEK;HIF1A
heme binding (GO:0020037),1/91,0.2835947674102115,0.3322714812194269,0,0,3.0612654320987653,3.857834050222409,CYBB
histone deacetylase binding (GO:0042826),1/93,0.2888389214514201,0.33590896791017005,0,0,2.9944142512077296,3.7187214705790064,SFPQ
endopeptidase activity (GO:0004175),2/315,0.31965672842621623,0.36901548796261724,0,0,1.7651982180623678,2.0132219525561776,MMP8;MMP9
thiol-dependent deubiquitinase (GO:0004843),1/106,0.32201490119774046,0.36902437582514785,0,0,2.621957671957672,2.9710908892199424,TNFAIP3
deubiquitinase activity (GO:0101005),1/112,0.3368074396256327,0.3831723029241697,0,0,2.4794794794794797,2.6982784378310085,TNFAIP3
omega peptidase activity (GO:0008242),1/113,0.33924172042330947,0.3831723029241697,0,0,2.457217261904762,2.6563560119679144,TNFAIP3
endopeptidase inhibitor activity (GO:0004866),1/115,0.34408387390877154,0.3858654871691224,0,0,2.413864522417154,2.575279237081068,LTF
nuclear receptor binding (GO:0016922),1/120,0.35603667068127076,0.3964379950138972,0,0,2.3118580765639587,2.387505646738297,HIF1A
magnesium ion binding (GO:0000287),1/146,0.4148120398489358,0.4586302130724149,0,0,1.8948275862068966,1.667315216096072,TKT
ubiquitin-protein transferase activity (GO:0004842),2/392,0.4204688833551243,0.46163366913814347,0,0,1.411123149151318,1.222575649416854,RNF213;TNFAIP3
cytokine activity (GO:0005125),1/173,0.4702472783401561,0.5127001576347535,0,0,1.595203488372093,1.2035756058997582,PPBP
small GTPase binding (GO:0031267),1/175,0.4741411245019245,0.5133803899779459,0,0,1.5767081736909323,1.1766189012479575,FLNA
transcription regulatory region nucleic acid binding (GO:0001067),1/212,0.5412913196519876,0.5820735423654936,0,0,1.297788309636651,0.7965794294743186,SFPQ
GTPase activity (GO:0003924),1/216,0.5480233416995438,0.585303841134887,0,0,1.2733850129198967,0.7658613695854986,DDX3X
transcription cis-regulatory region binding (GO:0000976),2/549,0.5992972249801366,0.6357409751478476,0,0,0.9980173545845457,0.5109824922657406,SFPQ;HIF1A
receptor ligand activity (GO:0048018),1/307,0.6773831613696418,0.7137527270807635,0,0,0.8905682643427741,0.346892544314651,GRN
"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",1/333,0.7070957287199041,0.7400935293934996,0,0,0.8197372824631861,0.28411210611287735,HIF1A
protein serine/threonine kinase activity (GO:0004674),1/344,0.7188383322306879,0.7474014447696556,0,0,0.793002915451895,0.26178516878778696,STK17B
sequence-specific DNA binding (GO:0043565),2/707,0.7349349800692195,0.7578302442886352,0,0,0.7680351613225452,0.2365342818076578,YBX1;HIF1A
sequence-specific double-stranded DNA binding (GO:1990837),2/712,0.7385224673640841,0.7578302442886352,0,0,0.7624280896647491,0.23109481651553196,SFPQ;YBX1
double-stranded DNA binding (GO:0003690),1/651,0.9110870344138938,0.9288354831362423,0,0,0.4119017094017094,0.038354989301281735,YBX1
RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),2/1149,0.9278132215811437,0.9337607422323048,0,0,0.46121541805321903,0.03455648969728971,HIF1A;RBMX
cis-regulatory region sequence-specific DNA binding (GO:0000987),2/1149,0.9278132215811437,0.9337607422323048,0,0,0.46121541805321903,0.03455648969728971,HIF1A;RBMX
RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),2/1359,0.9630864438193644,0.9630864438193644,0,0,0.3854816444725835,0.014498776505151384,HIF1A;RBMX
